Glibenclamide relaxes vascular smooth muscle constriction produced by prostaglandin F2α
- 19 March 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 195 (1) , 27-35
- https://doi.org/10.1016/0014-2999(91)90378-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary arteryEuropean Journal of Pharmacology, 1989
- Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the ratBritish Journal of Pharmacology, 1989
- Competitive antagonism by glibenclamide of cromakalim inhibition of twitch contractions in rabbit vas deferensEuropean Journal of Pharmacology, 1989
- AN ANALYSIS OF THE HAEMODYNAMIC EFFECTS OF TOLBUTAMIDE IN CONSCIOUS DOGSClinical and Experimental Pharmacology and Physiology, 1988
- Endothelium-dependent relaxation of canine basilar arteries. Part 1: Difference between acetylcholine- and A23187-induced relaxation and involvement of lipoxygenase metabolite(s).Stroke, 1987
- Adverse Cardiovascular Effects of Sulphonylurea DrugsMedical Toxicology, 1987
- ELECTROPHYSIOLOGICAL EVIDENCE FOR THE INHIBITION OF POTASSIUM PERMEABILITY IN PANCREATIC β‐CELLS BY GLIBENCLAMIDEQuarterly Journal of Experimental Physiology, 1984
- Cholinergic mechanism in the large cat cerebral artery.Circulation Research, 1982
- Clinical Pharmacology of Sulphonylurea Hypoglycaemic AgentsDrugs, 1981
- Effect of Intravenous Glibornuride and Tolbutamide on Myocardial ContractilityCardiology, 1979